POTENZA, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.863
EU - Europa 9.134
AS - Asia 8.396
SA - Sud America 1.189
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 16
Totale 41.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.611
GB - Regno Unito 2.850
CN - Cina 2.545
SG - Singapore 2.440
IT - Italia 1.913
HK - Hong Kong 1.688
SE - Svezia 1.167
BR - Brasile 968
DE - Germania 891
RU - Federazione Russa 558
VN - Vietnam 534
FI - Finlandia 389
UA - Ucraina 365
TR - Turchia 262
FR - Francia 250
KR - Corea 201
ID - Indonesia 196
IN - India 166
BG - Bulgaria 165
CA - Canada 151
NL - Olanda 79
AR - Argentina 75
BE - Belgio 64
CZ - Repubblica Ceca 63
IE - Irlanda 60
JP - Giappone 60
MX - Messico 53
PL - Polonia 52
BD - Bangladesh 51
ES - Italia 51
AT - Austria 50
EC - Ecuador 43
ZA - Sudafrica 43
LT - Lituania 39
IQ - Iraq 32
IR - Iran 27
MY - Malesia 23
AE - Emirati Arabi Uniti 22
BZ - Belize 22
CO - Colombia 22
MA - Marocco 22
CL - Cile 20
PK - Pakistan 19
EU - Europa 18
RO - Romania 18
PY - Paraguay 17
VE - Venezuela 17
CH - Svizzera 15
KE - Kenya 15
AU - Australia 14
PH - Filippine 14
SA - Arabia Saudita 14
DZ - Algeria 12
UZ - Uzbekistan 12
AZ - Azerbaigian 11
DK - Danimarca 11
EG - Egitto 11
IL - Israele 11
SK - Slovacchia (Repubblica Slovacca) 11
UY - Uruguay 11
SI - Slovenia 9
AL - Albania 8
JO - Giordania 8
PT - Portogallo 8
RS - Serbia 8
BO - Bolivia 7
GR - Grecia 7
NO - Norvegia 7
PE - Perù 7
JM - Giamaica 6
NP - Nepal 6
OM - Oman 6
PA - Panama 6
TW - Taiwan 6
KG - Kirghizistan 5
LU - Lussemburgo 5
MK - Macedonia 5
NG - Nigeria 5
AM - Armenia 4
BH - Bahrain 4
BW - Botswana 4
MD - Moldavia 4
TN - Tunisia 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CR - Costa Rica 3
GA - Gabon 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CY - Cipro 2
EE - Estonia 2
GT - Guatemala 2
GY - Guiana 2
IM - Isola di Man 2
KH - Cambogia 2
LK - Sri Lanka 2
Totale 41.716
Salva come PNG Salva come JPEG
Città #
Fairfield 2.630
Ashburn 2.218
Santa Clara 2.176
Southend 1.888
Hong Kong 1.676
Singapore 1.515
Woodbridge 1.514
Chandler 1.328
Houston 1.263
Seattle 1.027
Ann Arbor 891
Wilmington 856
Cambridge 832
Hefei 790
Nyköping 664
Jacksonville 658
Dearborn 590
London 519
Beijing 441
Modena 409
Chicago 403
Los Angeles 372
New York 346
San Diego 246
Helsinki 204
Munich 195
Seoul 179
Princeton 177
Ho Chi Minh City 167
Jakarta 167
Salt Lake City 166
Bologna 162
Sofia 162
Milan 148
Buffalo 146
Eugene 135
Moscow 134
Izmir 133
Fremont 124
Hanoi 122
Council Bluffs 111
Shanghai 111
Bremen 102
Dallas 102
The Dalles 97
Boardman 73
São Paulo 71
Tampa 67
Elk Grove Village 66
Redwood City 66
Des Moines 60
Brussels 54
Dublin 53
Turku 53
Nuremberg 52
Phoenix 51
Columbus 49
Reggio Emilia 48
Rome 48
Toronto 47
Frankfurt am Main 46
Brooklyn 44
San Jose 43
Tokyo 43
Warsaw 40
Denver 39
Dong Ket 38
Orem 38
Guangzhou 37
Montreal 37
Stockholm 37
Parma 36
Atlanta 35
Sterling 35
Vienna 34
Kent 33
Ottawa 33
Redondo Beach 33
Lancaster 32
Chennai 30
Da Nang 29
Miami 29
Brno 28
Kilburn 28
Las Vegas 27
Rio de Janeiro 27
Kunming 25
San Francisco 25
Falls Church 24
Johannesburg 23
Philadelphia 23
Washington 23
Amsterdam 22
Belize City 22
Belo Horizonte 22
Boston 22
Detroit 22
Paris 22
Wuhan 21
Brasília 20
Totale 30.381
Salva come PNG Salva come JPEG
Nome #
HHV-6A in syncytial giant-cell hepatitis 422
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 406
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 401
Kaposi's sarcoma after liver transplantation 360
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 357
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 349
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 341
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 338
B cells and herpesviruses: a model of lymphoproliferation 332
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 331
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 330
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 325
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 323
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 319
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 318
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 316
Early versus delayed palliative/supportive care in advanced cancer: An observational study 314
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 313
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 309
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 307
Acute appendicitis in adult neutropenic patients with hematologic malignancies 305
Translational challenges of human herpesvirus 6 chromosomal integration. 305
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 303
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 296
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 293
Rhodotorula infection in haematological patient: risk factors and outcome 292
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 292
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 291
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 291
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 287
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 286
Mucorales-specific T cells in patients with hematologic malignancies 284
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 283
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 282
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 282
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 281
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 279
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 278
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 278
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 277
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 277
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 276
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 275
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 275
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 275
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 275
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 273
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 273
Parvoviruses in blood donors and transplant patients, Italy 273
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 272
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 265
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 263
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 263
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 262
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 259
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 258
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 258
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 257
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 257
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 256
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 255
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 253
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 253
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 253
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 253
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 249
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 248
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 244
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 241
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 239
'Gloves and socks' papular purpuric syndrome following primary infection with parvovirus B19: a link between dermatologists and haematologists 238
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 237
Diagnosis of aspergillosis: Role of proteomics 237
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 236
Breast Location for De Novo Extramedullary Myeloid Sarcoma 235
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 234
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 233
Pain and emotional distress in leukemia patients at diagnosis. 232
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 230
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 230
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 230
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 229
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 229
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 228
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 226
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 225
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 225
How I treat HHV8/KSHV-related diseases in posttransplant patients. 224
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 224
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 222
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 221
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 221
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment 220
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 218
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 217
Immunity to polyomavirus BK infection: Immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity 216
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 216
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 214
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 213
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 213
Totale 27.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.652 0 0 0 0 0 435 304 513 218 556 338 288
2021/20223.733 247 433 370 185 85 173 203 181 349 315 622 570
2022/20234.019 510 454 278 366 545 502 105 429 429 74 167 160
2023/20242.910 102 141 189 267 527 275 313 437 59 90 185 325
2024/20258.829 294 120 157 574 1.524 1.252 628 483 1.254 482 908 1.153
2025/20267.959 1.231 634 1.263 1.851 2.680 300 0 0 0 0 0 0
Totale 42.222